Category Archives: Clinical Cardiology

For the first time in years, for 2019 active managers are outperforming index funds, and that should be a loud wake-up call to passive investors. After a more than 10-year bull market, the bull is tired. Continue reading →

SANTA CLARA, Calif.--(BUSINESS WIRE)--Cardiva Medical, Inc., an innovator in the field of vascular closure, today announced that positive results from the AMBULATE pivotal study demonstrating the safety and efficacy of the companys VASCADE MVP Venous Vascular Closure System compared to manual compression were published online in the Journal of the American College of Cardiology: Clinical Electrophysiology. The company also announced that it has received CE Mark certification in Europe for VASCADE MVP Continue reading →

A concerted effort is needed to address treatment gaps for aortic valve disease among underserved populations in the United States, authors of a new perspective say. Impediments to care can include socioeconomic issues, distance from quality treatment facilities, diagnostic and treatment referral bias, language and cultural barriers, and a variety of disease-related factors Continue reading →

Cardiva Medical, Inc., an innovator in the field of vascular closure, today announced that positive results from the AMBULATE pivotal study demonstrating the safety and efficacy of the companys VASCADEMVP Venous Vascular Closure System compared to manual compression were published online in theJournal of the American College of Cardiology: Clinical Electrophysiology. The company also announced that it has received CE Mark certification in Europe for VASCADE MVP. Continue reading →

Patients with STEMI presenting to the hospital in the middle of the night or on the weekend fare just as well as those treated during regular working hours, according to results from a large French hospital. At this high-volume center, there was no difference in the median time from first medical contact (FMC) to sheath insertion between STEMI patients presenting off-hours versus those who presented during regular working hours, nor was there any difference in the risk of death in the hospital or at 1 year. Our analysis demonstrates that a well-organized urban STEMI network allows [us] to bridge the gap between on-hours and off-hours management and provide the same quality of care whatever time of admission, report Benoit Lattuca, MD (Sorbonne University/Hpital Universitaire Piti-Salptrire, Paris, France), and colleagues online October 30, 2019, in the Journal of the American College of Cardiology. Continue reading →

This transcript has been edited for clarity. Abraham Verghese, MD: Hello. Continue reading →

In the setting of elective PCI, postprocedural increases in cardiac troponin T detected by high-sensitivity assays are associated with greater complexity and extent of underlying coronary disease, new data show. Continue reading →

MEDIA CONTACT Available for logged-in reporters only Newswise CLEVELAND Health care statistics for men are bleak: less than 50 percent have a primary care provider, their life expectancy is seven years less than women, fewer than half the men suffering from depression seek treatment and men have higher death rates than women in 14 of the top 15 leading causes of death. Continue reading →

(UPDATED) The risk of death following catheter ablation for atrial fibrillation is higher than rates observed in randomized controlled trials, with the majority of deaths occurring not during the procedure but rather in the 30 days after discharge, according to a large analysis of real-world data. Continue reading →

Despite an increase in public education and awareness efforts, heart disease continues to be the leading cause of death among adults in the US. In fact, the American Heart Association estimates that by 2035 45 percent of Americans will have at least one health issue related to heart disease an increase of five percent over the 2030 projection. Continue reading →